Transforming IBD Treatment Through Research.

Together, we are performing innovative research and conducting clinical trials to enhance treatment options for individuals living with inflammatory bowel disease (IBD).

About Lightner Lab

Leading the Way in IBD Research

At Scripps Research Institute and Calibr-Skaggs, the Lightner Lab is dedicated to advancing scientific understanding of inflammatory bowel disease (IBD) and improving treatment options for complex diseases. Our team is composed of leading researchers and healthcare professionals who are passionate about innovative clinical trials and cutting-edge research.


Our Research Focus

IBD Solutions

We focus on understanding inflammatory bowel disease and developing therapies that enhance patient outcomes and quality of life. Our research takes a multimodal approach to developing new safe and effective treatment strategies.


Recent Publications and Contributions

Explore Our Latest Research Publications

Explore our latest publications showcasing impactful research and breakthroughs in inflammatory bowel disease. Your support enables our continued work.

Lightner Lab News

Stay informed about the latest developments at Lightner Lab

Find press releases, updates on our research initiatives, and noteworthy events related to inflammatory bowel disease (IBD) and our ongoing clinical trials.

Nine new faculty join Scripps Research

Nine new faculty join Scripps Research

The newly appointed faculty are making transformative discoveries in areas ranging across drug discovery, neuroscience, chemistry, immunity and more. LA JOLLA, CA — Scripps Research is welcoming...

Read More $
ï“„

Get Involved

Become a Part of Our Community

Your involvement can make a significant difference in IBD research. Join us in our mission to improve lives.